Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  ACS Medicinal Chemistry Letters

• Publication date

  2015-03-03

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1021/ml5004603PMID 25893039PMCID PMC4394349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bisphosphonate prodrugs: synthesis and biological evaluation in HuH7 hepatocarcinoma cells.

  2014cited by this paper
• Inhibitory effect of novel S,N-bisphosphonates on some carcinoma cell lines, osteoarthritis, and chronic inflammation.

  2012cited by this paper
• Design of new arylamino-2-ethane-1,1-diyl- and benzoxazole-2-methylene-bisphosphonates vs cytotoxicity and chronic inflammation diseases. From hydrophobicity prediction to synthesis and biological evaluation.

  2012cited by this paper
• Bisphosphonamidate clodronate prodrug exhibits potent anticancer activity in non-small-cell lung cancer cells.

  2011cited by this paper
• Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.

  2011cited by this paper
• Pharmacology of bisphosphonates.

  2011cited by this paper
• Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic study.

  2010cited by this paper
• Differences between bisphosphonates in binding affinities for hydroxyapatite.

  2010cited by this paper
• An in vitro Assay to Measure Targeted Drug Delivery to Bone Mineral

  2010cited by this paper
• Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment.

  2010cited by this paper
• New Symmetrically Esterified m-Bromobenzyl Non-Aminobisphosphonates Inhibited Breast Cancer Growth and Metastases

  2009cited by this paper
• NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.

  2008cited by this paper
• Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo.

  2008cited by this paper
• Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro.

  2008cited by this paper
• An update on the pharmacology of bisphosphonates and analogues with lower bone affinity

  2008cited by this paper
• Managing metastatic bone pain: the role of bisphosphonates.

  2007cited by this paper
• Determinants of structure–function relationships among bisphosphonates

  2007cited by this paper
• Structure-activity relationships of various bisphosphonates

  2006cited by this paper
• A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma

  2006cited by this paper
• A new dimethyl ester bisphosphonate inhibits angiogenesis and growth of human epidermoid carcinoma xenograft in nude mice

  2006cited by this paper
• Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.

  2006cited by this paper
• A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases

  2004cited by this paper
• Bisphosphonate prodrugs.

  2002cited by this paper
• Bisphosphonate prodrugs: synthesis and in vitro evaluation of alkyl and acyloxymethyl esters of etidronic acid as bioreversible prodrugs of etidronate.

  2000cited by this paper
• Solid‐state NMR of bisphosphonates adsorbed on hydroxyapatite

  2000cited by this paper
• The mevalonate/isoprenoid pathway inhibitor apomine (SR-45023A) is antiproliferative and induces apoptosis similar to farnesol.

  2000cited by this paper
• Bisphosphonate prodrugs: synthesis and in vitro evaluation of novel acyloxyalkyl esters of clodronic acid.

  1999cited by this paper
• Metabolism of a bisphosphonate ester (PNU-91638) in rat.

  1997cited by this paper
• Simultaneous determination of clodronate and its partial ester derivatives by ion-pair reversed-phase high-performance liquid chromatography coupled with evaporative light-scattering detection.

  1997cited by this paper
• Bisphosphonates: a review of their pharmacokinetic properties.

  1996cited by this paper
• Metabolism of the bisphosphonate ester U-91502 in rats.

  1996cited by this paper
• N.m.r. Study of the P-C(OH)-P to P-C-O-P Rearrangement: Tetraethyl 1-Hydroxyalkylidenediphosphonates

  1962cited by this paper

• [161Tb]Tb-BPAMD as a High-Affinity Agent for Skeletal Targeting: Radiochemical and Biodistribution Insights

  2026cites this paper
• Development of a Medication-Related Osteonecrosis of the Jaw Prediction Model Using the FDA Adverse Event Reporting System Database and Machine Learning

  2025cites this paper
• Beyond the Bone Health: A Narrative Review Unveiling the Role of Bisphosphonates in Reducing the Risk of Myocardial Infarction

  2025cites this paper
• Ultrasound-assisted synthesis of new bisphosphonate–betulin conjugates and preliminary evaluation of their cytotoxic activity

  2025cites this paper
• Synthesis and preliminary anticancer evaluation of photo-responsive prodrugs of hydroxymethylene bisphosphonate alendronate.

  2024cites this paper
• Denosumab combined with radiotherapy as an alternative to surgery for advanced metastatic bone lesions and pathologic fractures: a retrospective case study of 38 patients

  2024cites this paper
• Research advances of nanomaterials for the acceleration of fracture healing

  2023cites this paper
• Advanced nanoscale drug delivery systems for bone cancer therapy.

  2023cites this paper
• Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review)

  2022cites this paper
• Scaffolds as Carriers of Drugs and Biological Molecules for Bone-Tissue Bioengineering

  2022cites this paper
• Targeting Agents Used in Specific Bone-Targeting Drug Delivery Systems: A Review

  2022cites this paper
• Hydroxy- and Amino-Phosphonates and -Bisphosphonates: Synthetic Methods and Their Biological Applications

  2022cites this paper
• Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanions

  2022cites this paper
• Recent advances in bone-targeting nanoparticles for biomedical applications

  2021cites this paper
• Immobilized Bisphosphonates as Potential Inhibitors of Bioprosthetic Calcification: Effects on Various Xenogeneic Cardiovascular Tissues

  2021cites this paper
• One-Pot Synthesis of Phosphinylphosphonate Derivatives and Their Anti-Tumor Evaluations

  2021cites this paper
• Zoledronate alters natural progression of tissue‐engineered vascular grafts

  2021cites this paper
• Three-Component Reaction of Diamines with Triethyl Orthoformate and Diethyl Phosphite and Anti-Proliferative and Antiosteoporotic Activities of the Products

  2020cites this paper
• Treatment With Bisphosphonates To Mitigate Calcification Of Elastin-Containing Bioprosthetic Materials.

  2020cites this paper
• Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs

  2020cites this paper
• Targeting anti-cancer agents to bone using bisphosphonates.

  2020cites this paper
• Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair.

  2019cites this paper
• ZnCl2-Mediated Double Addition of Dialkylphosphite to Nitriles for the Synthesis of 1-Aminobisphosphonates (ABPs).

  2019cites this paper
• Effect of Etidronate and Ibandronate on Cytosolic Ca2+ in HT29 and Parasite Cell Line from Echinococcus Granulosus sensu lato

  2019cites this paper
• 12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma.

  2019cites this paper
• Calcium Phosphates as Delivery Systems for Bisphosphonates

  2018cites this paper
• Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond

  2018cites this paper
• Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis.

  2018cites this paper
• Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics

  2018cites this paper
• Hydrophosphonylation of Alkynes with Trialkyl Phosphites Catalyzed by Nickel

  2017cites this paper
• Theoretical study of the deposition and adsorption of bisphosphonates on the 001 hydroxyapatite surface: Implications in the pathological crystallization inhibition and the bone antiresorptive action

  2017cites this paper
• Hydroxyapatite as a Nanomaterial for Advanced Tissue Engineering and Drug Therapy.

  2017cites this paper
• Biomineralization: From Material Tactics to Biological Strategy

  2017cites this paper
• New nano-hydroxyapatite in bone defect regeneration: A histological study in rats.

  2017cites this paper
• Hydroxyapatite as a nanomaterial for tissue engineering and drug therapy

  2017cites this paper
• Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth

  2017cites this paper
• Bone-seeking agents for the treatment of bone disorders

  2017cites this paper
• Nano-Hydroxyapatite Bone Substitute Functionalized with Bone Active Molecules for Enhanced Cranial Bone Regeneration.

  2017cites this paper
• Bisphosphonate-Functionalized Hydroxyapatite Nanoparticles for the Delivery of the Bromodomain Inhibitor JQ1 in the Treatment of Osteosarcoma.

  2017cites this paper
• [Formation of bone in critical calvarias defects in rats under the influence of bisphosphonate alendronate Na complex].

  2017cites this paper
• Physiologic Activity of Bisphosphonates – Recent Advances

  2016cites this paper
• Synthesis of medronic acid monoesters and their purification by high-performance countercurrent chromatography or by hydroxyapatite

  2016cites this paper
• N-Arylaminomethylenebisphosphonates Bearing Fluorine Atoms: Synthesis and Antiosteoporotic Activity

  2015cites this paper
• Synthesis of novel polymerizable molecules bearing bisphosphonate.

  2015cites this paper